MB
Metropolitan Bank Holding Corp. (MCB)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered solid profitability with diluted EPS of $1.76 and net income of $18.8M; NIM expanded 15 bps sequentially to 3.83% as loan yields rose and deposit costs fell .
- EPS beat S&P Global consensus ($1.76 vs $1.73); S&P’s revenue definition shows a miss ($69.9M vs $72.6M), while company-reported total revenues were $76.3M, highlighting definitional differences; estimates from S&P Global* .
- Strong balance sheet growth: loans up 4.3% q/q to $6.6B and deposits up 5.3% q/q to $6.8B; credit metrics stable though NPL ratio ticked up to 0.60% and ACL/loans to 1.12% .
- Capital return escalated: first-ever quarterly dividend ($0.15) and new $50M buyback authorization; board has authorized $100M YTD repurchases; management expects repurchases to be limited near book value .
- Guidance constructive: CFO now expects FY25 NIM ~3.80% (prior ~3.75%), operating expenses to average $45–$46M per quarter for the rest of 2025, with one-time IT spend of $8–$9M remaining; tax rate ~30% and loan growth potentially >12% for 2025 .
What Went Well and What Went Wrong
What Went Well
- Net interest margin expansion to 3.83% (+15 bps q/q; +39 bps y/y) supported by loan repricing and deposit cost decline; net interest income up ~10% q/q .
- Broad-based deposit growth (+$342M q/q) and strong loan originations ($492M in Q2), with diversified vertical contributions (municipal, trustee, lending) .
- Strategic capital return: completed initial $50M buyback at ~$56.90 average price and initiated a $0.15 dividend; board authorized an additional $50M repurchase .
- CEO tone confident on franchise resilience and diversified commercial banking model: “Our healthy balance sheet, together with strong earnings momentum, enables us to opportunistically capitalize on various strategic initiatives to support responsible growth.” .
What Went Wrong
- Non-interest income declined to $2.6M (−$1.0M q/q; −$3.5M y/y) driven by absence of BaaS revenue and non-recurring fees recognized in Q1 .
- Provision increased to $6.4M (from $4.5M), including a $2.4M reserve on a single non-accrual loan; NPL ratio rose modestly to 0.60% .
- CRE concentration increased (non-owner-occupied CRE at 371.9% of risk-based capital vs 367.0% in Q1), primarily due to funding of buybacks at the holding company—an investor watch point amid broader CRE scrutiny .
Financial Results
Core P&L and Margin Metrics (Company-defined “Total revenues” = NII + Non-interest income)
Q2 2025 Actual vs S&P Global Consensus
Values retrieved from S&P Global.
Note: S&P Global’s “Revenue” actual for Q2 2025 is 69,892,000*, which differs from the company’s “Total revenues” definition (NII + non-interest income). The table above compares company-reported total revenues to consensus for investor relevance; see Estimates Context for definitional details.
KPIs and Balance Sheet
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “Given robust results coupled with confidence in continued business strength, our board has authorized an additional $50 million repurchase program… As part of our multi-pronged approach… our board also approved an initial quarterly cash dividend.” .
- CFO: “We expect modest further expansion of the NIM… annual NIM this year will be about 5 bps higher, or approximately 3.80%… operating expenses to average approximately $45–$46 million per quarter for the remainder of 2025… one-time IT costs for the remainder of 2025 are expected to foot to $8–$9 million.” .
- CEO on macro/tariffs and asset quality: “We actively engage with our customers… feedback has not indicated any specific areas of concern… asset quality remains excellent.” .
Q&A Highlights
- Capital raise vs buybacks: Near-term capital raise unlikely; buybacks to be limited near book and used to support stock below current book value .
- Fee income replacement: Management focused on rebuilding fee-based revenues post-BaaS exit; expects progress beginning in 2026 .
- Originations mix: Heavy CRE in Q2 originations viewed as timing; expect balanced mix between C&I (incl. healthcare) and CRE for the year .
- Provision specifics: Of $6.4M provision, ~$2.4M tied to one existing non-performer .
- Deposit verticals: Municipal vertical gaining share nationally; EV-5, title/1031 pipelines strong; strategy remains core-funded .
- SNF portfolio/Medicaid: Management does not expect cuts to resident payments; views exposure as resilient .
Estimates Context
- Q2 2025 EPS beat: Actual $1.76 vs consensus $1.73*;
- Q2 2025 Revenue: S&P Global’s “Revenue” actual $69.9M vs consensus $72.6M*, implying a miss under S&P’s definition. Company-reported “Total revenues” (NII + non-interest income) were $76.3M .
- Forward consensus (S&P Global)*:
- EPS: Q3 2025 2.08; Q4 2025 2.20; Q1 2026 2.18; Q2 2026 2.38
- Revenue ($): Q3 2025 78.28M; Q4 2025 83.00M; Q1 2026 84.14M; Q2 2026 87.50M
Values retrieved from S&P Global.
Key Takeaways for Investors
- Margin momentum continues: NIM at 3.83% with CFO raising FY NIM guide to ~3.80%; hedging and deposit mix shifts should further support spreads .
- Core-funded growth: Deposits and loans grew strongly and broadly across verticals; management emphasizes lean, diversified sourcing over expensive team lift-outs .
- Credit steady but watchpoints: Provision rose and NPL ratio ticked up; ACL coverage strengthened; monitor CRE concentration and individual workout outcomes .
- Capital return accelerates: Dividend initiation and new $50M buyback authorization are shareholder-friendly catalysts; repurchases to be opportunistic near/under book .
- Expense trajectory transparent: H2 quarters to average $45–$46M OpEx; one-time IT spend lowered to $8–$9M remaining; tax rate ~30% .
- Loan growth outlook raised: Pipelines support >12% for FY25 under unchanged underwriting standards .
- Estimates likely adjust: EPS beat and revenue definitional differences suggest Street may revisit revenue framing; the NIM guide raise is supportive to out-year margin and earnings expectations .
Footnote: Values marked with * are retrieved from S&P Global.